CCO Independent Conference Coverage of CROI 2023: Clinical Impact of New HIV Data *

Learn about the latest data on HIV treatment strategies, prevention, and best practices with live webinars, rapid Capsule Summaries, and downloadable slides, and gain global perspectives from companion commentaries on key studies from CROI 2023.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc.

ViiV Healthcare

Target Audience

This program is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for patients with or at risk of HIV infection.

Program Learning Goal

The goal of this program is to improve the knowledge and competence of learners at applying new findings to optimize treatment for patients with HIV.

Learning Objectives

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention strategies

*ProCE is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.